CoChat

Current loss-of-function mutations in the thyrotropin receptor gene: when to investigate, clinical effects, and treatment

Open access
Cassio, Alessandra, Nicoletti, Annalisa, Rizzello, Angela, Zazzetta, Emanuela, Bal, Milva, Baldazzi, Lilia · 2012 · Journal of Clinical Research in Pediatric Endocrinology
Cited by 45

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

In tro duc ti onCongenital hypothyroidism (CH) is the most common endocrine disorder in infancy.It shows a considerable variability in etiopathogenesis and clinical aspects.Among these various disorders, resistance to thyroid-stimulating hormone (TSH) has been defined as a genetic disease, characterized by TSH serum levels above the normal range, normal or reduced thyroid hormone concentrations, normal sized or hypoplastic thyroid gland, in absence of anti-thyroid antibodies.Recently, the OMIM database for genetic disease (at the website www.ncbi.nlm.nih.gov)classified TSH resistance among the six forms of nongoitrous CH (CHNG) and loss-of-function (LOF) mutations in the TSH receptor (TSHR) gene were identified as the most frequent cause of TSH resistance (Table 1) (1,2).This review will focus on the TSH resistance due to LOF TSHR gene mutations.Data about the spectrum of the TSHR gene mutations, genotype-phenotype correlation, phenotypic variability, and criteria for clinical work-up will be presented and discussed with the help of recent studies on TSHR gene analysis in large populations.TSHR Physiology TSHR encoded by the TSHR gene (chromosome 14q31) (3) is a G-protein-coupled receptor with a seven-transmembrane domain (TMD) activating the classical G-protein-coupled effectors, adenylatecyclase (AC) and phospholipase C (PLC) and a large extracellular domain (ECD) responsible for high-affinity hormone binding (Figure 1).TSHR ECD is encoded by the first 9 exons and part of exon 10, whereas TMD and intracellular domain are encoded by the exon 10. ABS TRACTThyroid-stimulating hormone receptor (TSHR) loss-of-function (LOF) mutations lead to a wide spectrum of phenotypes, ranging from severe congenital hypothyroidism (CH) to mild euthyroid hyperthyrotropinemia.The degree of TSH resistance depends on the severity of the impairment of the receptor function caused by the mutation and on the number of mutated alleles In this review data about genotype-phenotype correlation and criteria for clinical work-up will be presented and discussed.Complete TSH resistance due to biallelic LOF TSHR mutations must be suspected in all patients with severe not syndromic CH and severe thyroid hypoplasia diagnosed at birth by neonatal screening.Partial forms of TSH resistance show a more heterogeneous hormonal and clinical pattern .In these cases TSH serum levels are above the upper limit of normal range for the age but with a very variable pattern, free thyroxine (T4) concentrations are within the normal range and thyroid size can be normal or hypoplastic at ultrasound scan.An early substitutive treatment with L-T4 must be mandatory in all patients with severe CH due to complete uncompensated TSH resistance diagnosed at birth by neonatal screening.The usefulness of substitutive treatment appears much more controversial in patients with subclinical hypothyroidism due to partial TSH resistance in whom the increased TSH concentration should be able to compensate the mild functional impairment of the mutant receptor.Together with standard criteria we recommend also an accurate clinical work-up to select patients who are candidates for a LOF TSHR mutation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.4274/jcrpe.864

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 45

Metadata

Authors
Cassio, A., Nicoletti, A., Rizzello, A., Zazzetta, E., Bal, M., & Baldazzi, L.
Venue
Journal of Clinical Research in Pediatric Endocrinology
Published
2012-11-15
Volume
4
Issue
4
Pages
29-39
ISSN
1308-5727 (ISSN-L)
OpenAlex
W2100884108
Cited by
45
References
3
FWCI
2.53
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Current loss-of-function mutations in the thyrotropin receptor gene: when to investigate, clinical effects, and treatment. https://app.cochat.ai/papers/10.4274/jcrpe.864
The paper
Cassio, A., Nicoletti, A., Rizzello, A., Zazzetta, E., Bal, M., & Baldazzi, L. (2012). Current loss-of-function mutations in the thyrotropin receptor gene: when to investigate, clinical effects, and treatment. Journal of Clinical Research in Pediatric Endocrinology. https://doi.org/10.4274/jcrpe.864

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.